Disseminated tumour cells as a prognostic biomarker in colorectal cancer

[1] Borgen E(1999)Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells Cytother 1 377-388

[2] Naume B(2002)Metastasis: dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 563-572

[3] Nesland JM(1932)The classification of cancer of the rectum J Pathol Bacteriol 35 323-332

[4] Kvalheim G(2011)Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern Breast Cancer Res Treat 125 729-738

[5] Beiske K(2005)Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment Clin Cancer Res 11 5337-5341

[6] Fodstad O(2006)A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 885-892

[7] Diel I(2002)Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients Clin Cancer Res 8 444-449

[8] Solomayer EF(2004)Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients Clin Cancer Res 10 3457-3464

[9] Theocharous P(2009)Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 162-171

[10] Coombes RC(2009)Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches Future Oncol 5 1083-1098

[1] Borgen E(1999)Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells Cytother 1 377-388

[2] Naume B(2002)Metastasis: dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 563-572

[3] Nesland JM(1932)The classification of cancer of the rectum J Pathol Bacteriol 35 323-332

[4] Kvalheim G(2011)Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern Breast Cancer Res Treat 125 729-738

[5] Beiske K(2005)Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment Clin Cancer Res 11 5337-5341

[6] Fodstad O(2006)A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 885-892

[7] Diel I(2002)Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients Clin Cancer Res 8 444-449

[8] Solomayer EF(2004)Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients Clin Cancer Res 10 3457-3464

[9] Theocharous P(2009)Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 162-171

[10] Coombes RC(2009)Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches Future Oncol 5 1083-1098